Table 3.
Univariate and Multivariate Analyses of Factors Related With iPD in Advanced NSCLC.
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| Total MPs ≥3000 events/μL | 4.714[1.364,16.295] | 0.014 | 1.242[0.180,8.576] | 0.826 |
| PMPs, ≥80 events/μL | 20.444[3.888,107.494] | <0.0001 | 10.346[1.239,86.410] | 0.031 |
| T-LyMPs, ≥150 events/μL | 3.818[1.125.12.955] | 0.032 | 1.733[1.239,86.410] | 0.644 |
| NLR, ≥3.3 | 4.464[1.277,15.608] | 0.019 | 5.358[0.541,53.051] | 0.151 |
| CEA, ≥5.0 ng/ml | 4.964[1.403,17.557] | 0.013 | 2.019[0.363,11.229] | 0.422 |
| CYFRA21 -1, ≥4 ng/ml | 2.571[0.772,8.567] | 0.124 | 1.864[0.370,9.378] | 0.450 |
| LDH, ≥200U/L | 2.762[0.543,14.057] | 0.221 | 0.864[0.101,6.438] | 0.491 |
MPs, microparticles; PMPs, platelet-derived microparticles; T-LyMPs, T-lymphocyte-derived microparticles; NLR, neutrophil-lymphocyte ratio; CEA, carcino-embryonic antigen; CYFRA21 -1, cytokeratin 19 fragment; LDH, lactate dehydrogenase.